MERIBENDAN
UNII 4WYD7I9GF4

Substance Identification & Data

This profile provides standardized clinical and technical data for Meribendan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4WYD7I9GF4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 119322-27-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4WYD7I9GF4
CAS Registry Number
119322-27-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MERIBENDAN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C15H14N6O
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
FDWDHUONLKCDBV-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
6456
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(n[nH]c1)-c2[nH]c3cc(C=4C(C)CC(=O)NN4)ccc3n2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Meribendan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MERIBENDAN

Common Names & Synonyms

MERIBENDAN [INN]

Systematic Nomenclature

4,5-DIHYDRO-5-METHYL-6-(2-PYRAZOL-3-YL-5-BENZIMIDAZOLYL)-3(2H)-PYRIDAZINONE